Category: Biolase Technology Inc.Syndicate content

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

February 10, 2015 by Brad Perriello

JenaValve names medtech veteran Jan Keltjens to be its interim chairman & CEO, just 7 months after putting former AtriCure chief David Drachman in the corner office.

JenaValve taps medtech vet Keltjens for interim CEO | Personnel Moves

JenaValve tapped a medtech veteran with a string of successful exits behind him as interim chairman & CEO, replacing another medical device vet, David Drachman, after just 7 months.

Vascular Dynamics reports raising $10 million in funding round | Medtech funding for the week of November 10, 2014

November 14, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Vascular Dynamics raises $10m; Spiracur raises $16m from GE Capital; Biolase lands $35m private placement; Monteris Medical raises $30m Series B round for NeuroBlate robotic brain tumor laser

Vascular Dynamics raises $10m

November 7, 2014 by Val Kennedy

Vascular Dynamics raises $10m

Biolase lands $35m private placement

November 11, 2014 by Val Kennedy

Dental laser maker Biolase lands a $35 million private placement with a group of investors that includes its chairman, chief executive officer and top stockholders.

Biolase lands $35m private placement

Dental laser maker Biolase (NSDQ:BIOL) said in landed a $35 million private placement with a group of investors that includes its chairman, CEO and top stockholders.

Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves

September 2, 2014 by Brad Perriello

Bluegrass Vascular Technologies taps former ArthroCare R&D chief Gabriele Niederauer to be its new president & CEO.

Bluegrass Vascular taps ex-ArthoCare R&D chief Niederauer for CEO | Personnel Moves

Bluegrass Vascular Technologies said it named Gabriele Niederauer its new president & CEO, hard on the heels of a Series A funding round that brought in $4.5 million for its Surfacer central venous catheter.

Medtronic CEO Ishrak seeks to reassure employees on MDT-COV deal | The week in medtech M&A

August 20, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal; Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; Medtronic founder Bakken backs Covidien buy; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Allergan CFO Edwards steps down amid hostile Valeant takeover bid

Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal

August 15, 2014 by Brad Perriello

Allergan CFO Edwards steps down amid hostile Valeant takeover bid | Personnel Moves

August 18, 2014 by Brad Perriello

Allergan CFO Jeff Edwards is stepping down amid a $44 billion hostile takeover bid from Valeant Pharmaceuticals and Pershing Square Capital Management.

Allergan CFO Edwards steps down amid hostile Valeant takeover bid | Personnel Moves

Allergan (NYSE:AGN) said today that longtime CFO Jeff Edwards is stepping down to honor a commitment he made to his family earlier this year, replaced by treasurer Jim Hindman effective immediately.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.